Expression of tumor associated antigens CA 15-3 and CA 19-9 in trophoblast of the normal human placenta

Mucin 1 (MUC1) is abundantly expressed by various organs, including human placenta and endometrium. Since glycan modifications of MUC1 are potentially relevant for physiological as well as pathological processes, this study was aimed at establishing an expression profile of two MUC1 glycoepitopes, CA 15-3 and CA 19-9, in trophoblast throughout pregnancy. Immunohistochemical analysis of normal placenta demonstrated that trophoblast cells express both mucin antigens throughout gestation with a distinct staining pattern. The staining of vinous trophoblast was non-uniform for both antigens, and stronger for CA 15-3. Only a proportion of extravillous trophoblast of the cell column, in decidual stroma or lining blood vessels was also stained. Whether the studied MUC1 glycoforms can be linked to trophoblast cells invasion remains to be established.

CA 15-3, CA 19-9; Glycosylation; Trophoblast

[1] Singh P.K., Hollingsworth M.A.: “Cell-surface associated mucins in signal transduction”. TRENDS in Cell Biol., 2006, 16, 467.

[2] Hanisch F.-G., Müller S.: “MUC1: the polymorphic appearance of a human mucin”. Glycobiology, 2000, 10, 439.

[3] Aplin J.D.: “MUC-1 glycosylation in endometrium: possible roles of the apical glycocalyx at implantation”. Hum. Reprod., 1999 (suppl. 2), 17.

[4] Meseguer M., Aplin J.D., Caballero-Campo P., O’Connor J.E.O., Martin J.C., Remohi J. et al.: “Human endometrial MUC1 is upregulated by progesterone and down-regulated in vitro by the human blastocyst”. Biol. Reprod., 2001, 64, 590.

[5] Carson D.D., Julian J., Lessey B.A., Prakobphol A., Fisher S.J.: “MUC1 is a scaffold for selectin ligands in the human uterus”. Front. Biosci., 2006, 11, 2903.

[6] Jeschke U., Richter D.U., Hammer A., Briese V., Friese K., Karsten U.: “Expression of the Thomsen-Friedenreich antigen and its putative carrier protein mucin1 in the human placenta and in trophoblast cells in vitro”. Histochem. Cell. Biol., 2002, 117, 219.

[7] Shyu M.K., Lin M.C., Liu C.H., Shih J.C., Lee C.N., Chen H.Y. et al.: “MUC1 expression is increased during human placental development and suppresses trophoblast-like cell invasion in vitro”. Biol. Reprod., 2008, 79, 233.

[8] Spiro R.: “Protein glycosylation: nature, distribution, enzymatic formation, and disease implication of glycopeptide bonds”. Glycobiology, 2008, 12, 43.

[9] Brockhausen I., Kuhns W.: “Glycosylation in cancer and oncogenic transformation”. In: Glycoprotein and human disease, Brockhausen I., Kuhns W. (eds.), Heidelberg: Medical Intelligence Unit, Springer, 1997, 157.

[10] Julian J., Carson D.D.: “Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells”. Biochem. Biophys. Res. Commun., 2002, 293, 1183.

[11] Duffy M.J.: “CA 15-3 and related mucins as circulating markers in breast cancer”. Ann. Clin. Biochem., 1999, 36, 579.

[12] Steinberg W.: “The clinical utility of the CA 19-9 tumor-associated antigen”. Am. J. Gastroenterol., 1990, 85, 350.

[13] Kobayashi F., Sagawa N., Nanbu Y., Nakamura K., Nonogaki M., Ban C. et al.: “Imunohistochemical localization and tissue levels of tumor-associated glycoproteins CA 125 and CA19-9 in the deciduas and fetal membranes at various gestational age”. Am. J. Obstet Gynecol., 1989, 160, 1232.

[14] Minas V., Mylonas I., Schiessl B., Mayr D., Schulze S., Friese K. et al.: “Expression of the blood-group-related antigens Sialyl Lewis a, Sialyl Lewis x and Sialyl Lewis y in term placentas of normal, preeclampsia, IUGR- and HELLP-comlicated pregnancies”. Histochem. Cell. Biol., 2007, 128, 55.

[15] Vic´ovac Lj, Božic´ M., Bojic´-Trbojevic´ Ž., Golubovic´ S.: “Carcinoembryonic antigen and related molecules in normal and transformed trophoblast”. Placenta, 2007, 28, 85.

[16] De Souza M.M., Surveyor G.A., Price R.E., Julian R., Kardon R., Zhou S. et al.: “MUC1/episialin: a critical barrier in the female reproductive tract”. J. Reprod. Immunol., 1999, 45, 127.

[17] Cao Y., Blohm D., Ghadimi M., Stosiek P., Xing P.-X., Karsten U.: “Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogenous tumor-associated aberrations in glycosylation”. J. Histochem. Cytochem., 1997, 45, 1547.

[18] Paszkiewicz-Gadek A., Porowska H., Sredzinska K.: “Expression of MUC1 mucin in full-term pregnancy human placenta”. Adv. Med. Sci., 2008, 53, 54.

[19] Yu L.-G., Andrews N., Zhao Q., McKean D., Williams J.F., Connor L.J. et al.: “Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion”. J. Biol. Chem., 2006, 282, 773.

[20] Božic´ M., Petronijevic´ M., Milenkovic´ S., Atanackovic´ J., Lazic´ J., Vic´ovac L.J.: “Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblast disease”. Placenta, 2004, 25, 797.